Sign in
4

Changes in Ownership

BOSTON SCIENTIFIC CORP Filed Acc 0001225208-22-002675

EVP Global Chief Med Officer gave up 326 shares (to pay taxes)

  • EVP Global Chief Med Officer acquired 1,108 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Meredith Ian T · EVP Global Chief Med Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-02-15 Exercise or conversion : show line 1 in the form +1,108 31,947 D
2022-02-15 Shares withheld for taxes : show line 2 in the form −326 $44.01 $14,347 31,621 D

Table II: Derivative

3 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2022-02-15 Exercise or conversion : show line 3 in the form Deferred Stock Units −1,108 2023-02-15 1,108 1,108 D
2022-02-16 Grant or award : show line 4 in the form Restricted Stock Units +4,525 2026-02-16 4,525 4,525 D
2022-02-16 Grant or award : show line 5 in the form Stock Option (Right to Buy) +12,941 $44.19 2032-02-16 12,941 12,941 D
Loading xslF345X03/doc4.xml…